BioSpace News Archive

CyberMDX, a leading healthcare cybersecurity provider delivering visibility and threat prevention for medical devices and clinical networks, today announced that the company has received Frost & Sullivan’s 2020 Technology Innovation Leadership Award as the leader in medical devices and assets security technology innovation in North America

Funding comes after the company meets key milestones with new collaborations and studies, product enhancements, and reimbursement progress

The study, to be led by the University of California, Irvine, investigates how digital tools can aid clinical outcomes

Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, today announced that Kellie Sears has been appointed to its executive team as Chief Human Resources Officer. She joins AskBio from Allergan and will have responsibility for all aspects of human capital management, including talent acquisition and administration, leadership development, compensation and benefits

Enzolytics, Inc. today announced the execution of a non-binding letter of intent (the “LOI”) to merge with BioClonetics Immunotherapeutics, Inc. (“BCLS” or “BioClonetics”) a biotech company located in Dallas Texas.

Mednet, a provider of eClinical solutions for the global life sciences community and MedTrials, a contract research organization (CRO) providing a wide-range of specialized clinical research services, announced

Study will evaluate the impact of remote patient monitoring on clinical outcomes, readmission rates, and patient satisfaction following a transcatheter aortic valve replacement procedure

Poseida Therapeutics, Inc., (Nasdaq: PSTX), a clinical-stage biopharmaceutical company dedicated to utilizing proprietary gene engineering platform technologies to create next generation cell and gene therapeutics with the capacity to cure, today will present data related to its proprietary manufacturing process designed to optimize its CAR-T product candidates.

Louisiana State University’s (LSU) Reilly Center for Media & Public Affairs has teamed up with former New Orleans Mayor Mitch Landrieu’s E Pluribus Unum organization on new research that studies the lived experience of COVID-19’s Black residents and essential workers throughout the Baton Rouge metro area.

The Jerome Canady Research Institute for Advanced Biological and Technological Sciences (JCRI-ABTS) in collaboration with US Medical Innovations, LLC (USMI) announced today that Canady Helios™ Cold Plasma (CHCP) has been used as an effective inhibitor of cell viability in breast cancer molecular subtypes.